%0 Journal Article
%T Congenital stromal corneal dystrophy in a Spanish family: Clinical, genetic and histological analysis.
%A Gómez-Calleja V
%A Burgos-Blasco B
%A Méndez-Fernández R
%A Pérez-García P
%A Ariño-Gutiérrez M
%A Borrego-Sanz L
%A Colino Gallardo AM
%A Díaz-Valle D
%J J Fr Ophtalmol
%V 47
%N 4
%D 2024 Apr 13
%M 38484481
%F 1.194
%R 10.1016/j.jfo.2024.104138
%X OBJECTIVE: To present the clinical, genetic, and histopathological features of the ninth family affected by congenital stromal corneal dystrophy (CSCD) to date.
METHODS: Twelve cases of a Spanish family affected by CSCD were analyzed regarding history, visual acuity (VA, decimal scale), an ophthalmologic exam and specular microscopy. Five eyes were treated by deep anterior lamellar keratoplasty (DALK), and thirteen eyes by penetrating keratoplasty (PK). In the two last generations, a genetic study was performed.
RESULTS: Most of the patients affected were born with opaque corneas except for three, whose corneas were clear at birth. Biomicroscopy showed a whitish diffuse stromal opacity with an unaltered epithelium, causing poor VA (from hand motions to 0.4). Patients treated with PK presented mean postoperative VA of 0.19±0.20 over a follow-up time of 235.3±101.4months with 38% recurrences. Patients who underwent DALK experienced VA improvement to 0.17±0.11 over a follow-up time of 10.8±2.6months without signs of recurrence. In the latter, the big bubble technique was not achieved, so a manual technique was performed. The genetic study showed heterozygosis for a 1-bp deletion at nucleotide 962 in exon 8 of the decorin gene.
CONCLUSIONS: CSCD is a rare entity, which should be treated by DALK whenever possible, obtaining better results than PK. Close monitoring of children of affected individuals is important, because CSCD can progress during the early years of life.